The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection
✍ Scribed by P A Barrow
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2001
- Tongue
- English
- Weight
- 89 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0268-2575
- DOI
- 10.1002/jctb.436
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A brief history of the use of lytic bacteriophages in bacterial disease therapy is presented. After early disillusionment with the idea following poor experimental work, control of phages and field trials, studies were set up in the 1980's in the UK to study their use in farm animal infections. Work with E. coli septicaemia and diarrhoea has shown that phages can be highly effective prophylactically and therapeutically and more effective than antibiotics. There is considerable potential for their use in a limited number of infection types in both man and animals.
© 2001 Society of Chemical Industry
📜 SIMILAR VOLUMES
## Abstract Meniscus injury is a frequently encountered clinical orthopedic issue and is epidemiologically correlated to osteoarthritis. The development of new treatments for meniscus injury is intimately related to the appropriateness of animal models for their investigation. The purpose of this s
The use of antibodies to detect chemical carcinogen-induced DNA damage involves quantitative determination and morphological localization utilizing antisera specific for carcinogen-DNA adducts. In recent years a large number of polyclonal and monoclonal antisera have been produced against individual
## Abstract Radiocomplexation of Teicoplanin (TIN), a new glycopeptide antibiotic with technetium‐99m, was investigated. The ^99m^Tc‐TIN complex was assessed for its radiochemical permanence, __in vitro__ stability in serum, binding with methicillin‐resistant __Staphylococcus aureus__ (MRSA), biodi